{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:34:26Z","timestamp":1789256066616,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1156391"],"award-info":[{"award-number":["APP1156391"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,8,1]]},"DOI":"10.1038\/s41416-022-01905-4","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T06:11:00Z","timestamp":1657692660000},"page":"377-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["New insights into the unique nature of colorectal cancer peritoneal metastases\u2014rethinking HIPEC"],"prefix":"10.1038","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5003-0433","authenticated-orcid":false,"given":"Robert G.","family":"Ramsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"1905_CR1","doi-asserted-by":"crossref","unstructured":"Laoukili J, Constantinides A, Wassenaar EC, Elias SG, Raats DA, van Schelven SJ, et al. Peritoneal metastases from colorectal cancer belong to consensus molecular subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity. Br J Cancer. 2022 (this issue).","DOI":"10.1038\/s41416-022-01742-5"},{"key":"1905_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/SLA.0000000000003485","volume":"270","author":"M Raoof","year":"2019","unstructured":"Raoof M, Haye S, Ituarte PHG, Fong Y. Liver resection improves survival in colorectal cancer patients: causal-effects from population-level instrumental variable analysis. Ann Surg 2019;270:692\u2013700.","journal-title":"Ann Surg"},{"key":"1905_CR3","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/SLA.0000000000002829","volume":"270","author":"S Renaud","year":"2019","unstructured":"Renaud S, Seitlinger J, Lawati YA, Guerrera F, Falcoz PE, Massard G, et al. Anatomical resections improve survival following lung metastasectomy of colorectal cancer harboring KRAS mutations. Ann Surg. 2019;270:1170\u20137.","journal-title":"Ann Surg."},{"key":"1905_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cortes-Guiral","year":"2021","unstructured":"Cortes-Guiral D, Hubner M, Alyami M, Bhatt A, Ceelen W, Glehen O, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Prim. 2021;7:91.","journal-title":"Nat Rev Dis Prim"},{"key":"1905_CR5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"1905_CR6","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1158\/1078-0432.CCR-20-0073","volume":"26","author":"V Narasimhan","year":"2020","unstructured":"Narasimhan V, Wright JA, Churchill M, Wang T, Rosati R, Lannagan TRM, et al. Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases to direct personalized therapy. Clin Cancer Res. 2020;26:3662\u201370.","journal-title":"Clin Cancer Res."},{"key":"1905_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.trecan.2019.12.008","volume":"6","author":"W Ceelen","year":"2020","unstructured":"Ceelen W, Ramsay RG, Narasimhan V, Heriot AG, De Wever O. Targeting the tumor microenvironment in colorectal peritoneal metastases. Trends Cancer. 2020;6:236\u201346.","journal-title":"Trends Cancer."},{"key":"1905_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366.","journal-title":"Lancet Oncol."},{"key":"1905_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1245\/s10434-021-10829-x","volume":"29","author":"M Flood","year":"2022","unstructured":"Flood M, Narasimhan V, Wilson K, Lim WM, Ramsay R, Michael M, et al. Organoids as a robust preclinical model for precision medicine in colorectal cancer: a systematic review. Ann Surg Oncol. 2022;29:47\u201359.","journal-title":"Ann Surg Oncol."},{"key":"1905_CR10","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1158\/1535-7163.MCT-21-0067","volume":"20","author":"KM Fujihara","year":"2021","unstructured":"Fujihara KM, Corrales Benitez M, Cabalag CS, Zhang BZ, Ko HS, Liu DS, et al. SLC7A11 Is a superior determinant of APR-246 (eprenetapopt) response than TP53 mutation status. Mol Cancer Ther. 2021;20:1858\u201367.","journal-title":"Mol Cancer Ther."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01905-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01905-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01905-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T23:22:24Z","timestamp":1659482544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01905-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8,1]]}},"alternative-id":["1905"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-01905-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RGR receives research and engineering support from Fisher and Paykel Healthcare, as well as travel and accommodation expenses and research support from the National Health and Medical Research Council of Australia. RGR is the President of the International Society for the Study of the Pleura and Peritoneum (ISSPP), Group Leader of the Differentiation and Transcription Laboratory and a Professor with The Sir Peter MacCallum Department of Oncology and Department of Clinical Pathology, The University of Melbourne. MF is a general surgeon and PhD candidate at The University of Melbourne, Australia.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}